Cached score snapshot

US.TECH · Bio-Techne

110分制 54.8/110;5D動能v2 1/50;排序分 55.8/160

Ranking score 55.8/160
Main score 54.8/110
5D momentum v2 1/50
Rank #282
Setup grade F 24.2

Score breakdown

避免

Medium twelvedata

Score and price trend

F 24.2 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 06-12 07-17 08-19 09-22 10-20 $50.72$69.38$88.03 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.226 · anchors 120 +1.15% -0.44% / +3.37% 65% 1.3% Actual outcome pending · 1 / 3 bars observed
30D observation +9.07% -0.01% / +15.60% 75% 8.8% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +1.02% -0.80% / +3.30% 64.4% 1.9% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-06-12 → 2026-10-20 · 90 archived points · 2 Improving turn signal · 6 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 55.8
Display grade 避免
Model version cursor_18_27_news_v2_160
Main score 54.8/110 (避免)
5D momentum v2 1/50 (弱)
Score with momentum v2 55.8/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 72.327
ma50 71.8724
close 72.31
prevClose 72.43
avgVolume20 2346639
volumeRatio 0.88
changePercent -0.17

Metrics snapshot

close 72.31
volume 2059387
changePercent -0.17

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 54.8/110
Main rating 避免
5D momentum v2 1/50
Score with momentum v2 55.8/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.5/5 · 較差

Dimension score 2.5/5
Dimension grade 較差

Sub-items

pbPoints 0.2
pePoints 0.2
epsPoints 0
roePoints 0
debtPoints 0.5
marginPoints 0.4
turnoverUsdM 148.9143
volumePoints 0.5
revenuePoints 0
dividendPoints 0.3
marketCapPoints 0.4

資金流 — 5.2/20 · 較差

Dimension score 5.2/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 0.8
obvPoints 0.8
vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.TECH
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 12.2/15 · 優秀

Dimension score 12.2/15
Dimension grade 優秀

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 15.3

trend

score 3.4

details

qqq

ma20 717.385
ma50 711.3218
name QQQ
close 718.36
points 2

spy

ma20 768.6995
ma50 757.5966
name SPY
close 765.96
points 1.4
source twelvedata+fred
atrPct 0.2401
atrPoints 4
cciPoints 2.4
vixPoints 2.4
marketTrendPoints 3.4

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 4
catalystCount 0
catalystPoints 2

風險管理 — 7.8/10 · 良好

Dimension score 7.8/10
Dimension grade 良好

Sub-items

position

score 1.6

details

atrPct 0.2401
turnoverUsdM 148.9143
liquidityPoints 0.4
volatilityPoints 1.2
rrPoints 1.8

stopLevels

symbol US.TECH
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 71.9628

strength_details

ma_score 2
atr_score 2.5
rsi_score 2
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 5
stop_loss_percent 0.5
take_profit_price 75.9255
target_multiplier 1.9
technical_strength 1.75
take_profit_percent 5
positionPoints 1.6
stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.6667
stopLossPercent 3
diversificationPoints 2

技術信號 — 21.1/30 · 良好

Dimension score 21.1/30
Dimension grade 良好

Sub-items

bbPoints 2.4
adxPoints 3
sarPoints 1.8
vcpPoints 3
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 3
vcp_reason 波幅收縮(1.4%→0.6%);量縮(v10/v30=0.64);跌縮量(近10日5日);站上MA50;Ready=Y;Confirm=N

vcp_metrics

up_days 4
vol_ref 3071610
down_days 5
vcp_ready true
above_ma50 true
avg_vol_10 1975930
avg_vol_20 2410545
avg_vol_30 3071610
range_pct_10 0.0061
range_pct_20 0.0086
range_pct_30 0.0144
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok true
up_expand_days 0
breakout_20d_ok false
vol_ratio_10_30 0.6433
dist_to_20d_high 0.0043
down_shrink_days 5
breakout_level_20d 72.62
vcp_breakout_confirm false
contraction_ratio_10_30 0.4231
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.7
rsiKdjPoints 3.2
volumeWeight 2
maCrossPoints 2.4
shortRsiPoints 0.4
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 0.8

情緒分析 — 4/10 · 較差

Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 4
negativeHits 0
positiveHits 1
sentimentScoreRaw 0.6

sentimentData

raw {"id":141365716,"url":"https://finnhub.io/api/news?id=a5ef3603445d8aa9a0dd109ccf0a962292f51f02adabd49ffa75d0ac6f6393df","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bio-Techne (NASDAQ:TECH) and its peers.","category":"company","datetime":1788214120,"headline":"Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks"}, {"id":141206752,"url":"https://finnhub.io/api/news?id=659ee02b225f8ed4a921b6c898a8d79914a526a79eab67069f99e681ffb2582e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.","category":"company","datetime":1786626060,"headline":"TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises"}, {"id":141204891,"url":"https://finnhub.io/api/news?id=145fc12944ce1e55b01af88717d7fcd693646a77f5e8c53179970f0cfe5a49d6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Techne (TECH) delivered earnings and revenue surprises of 0.00% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1786535402,"headline":"Techne (TECH) Q4 Earnings Meet Estimates"}, {"id":141202745,"url":"https://finnhub.io/api/news?id=ede2069c356f711c5c50a96d08642cfb212030b7caf9c085e6134f46c062f61d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Life sciences company Bio-Techne (NASDAQ:TECH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.3% year on year to $321.2 million. Its non-GAAP profit of $0.52 per share was in line with analysts’ consensus estimates.","category":"company","datetime":1786534647,"headline":"Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales"}
raw_source {"id":141949006,"url":"https://finnhub.io/api/news?id=00df6df6df67101935570b3d09b4f6fb117c7f4bf5fcbd493dfc9d008f76108f","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"TECH","summary":"Stay updated with the S&P500 stocks that are on the move in today's pre-market session.","category":"company","datetime":1788870900,"headline":"These S&P500 stocks are moving in today's pre-market session"}, {"id":141365715,"url":"https://finnhub.io/api/news?id=ee3edec51f2a0769452f44c0254fa97b00f03c804dffd9bcb7fd5748b9ec87a4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced significant progress toward its climate and sustainability objectives, including validation of its greenhouse gas reduction targets by the Science Based Targets initiative (SBTi) and substantial reductions in operational emissions during fiscal year 2026.","category":"company","datetime":1788262200,"headline":"Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals"}, {"id":141371333,"url":"https://finnhub.io/api/news?id=530e9947363819acf6e2f8d541c54ea3bd19cbcc5e4b1a633a9b1554f43e1d1f","image":"","source":"Benzinga","related":"TECH","summary":"Fiscal 2026 highlights:Science Based Targets initiative validates Bio-Techne's Scope 1, 2 and 3 greenhouse gas reduction targetsMarket-based Scope 1 and 2 emissions reduced 49% year-over-yearMore than half of the","category":"company","datetime":1788244574,"headline":"Bio-Techne Announces SBTi Validation Of 70% Scope 1 & 2 Emissions Reduction Target By FY2031 And Supplier Engagement Commitment, Reporting Significant Operational Emissions Cuts In FY2026"}, {"id":141365716,"url":"https://finnhub.io/api/news?id=a5ef3603445d8aa9a0dd109ccf0a962292f51f02adabd49ffa75d0ac6f6393df","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bio-Techne (NASDAQ:TECH) and its peers.","category":"company","datetime":1788214120,"headline":"Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks"}, {"id":141326656,"url":"https://finnhub.io/api/news?id=f0ee289a15577c07a4f88b461b3b9df0cab874642345723232053d6898832f08","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972341389/image_1972341389.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"TECH","summary":"Ruane, Cunniff & Goldfarb Q2 2026 13F: key holdings, new buys & trims, and Sequoia Fund vs S&P 500. Read here for a detailed investment analysis.","category":"company","datetime":1787781184,"headline":"Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2026 Update"}, {"id":141365510,"url":"https://finnhub.io/api/news?id=db75d1ced2a8c3d0024bd9d7d5a4f5c9b286c68130e8836fd45d69e34e43e3f5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.","category":"company","datetime":1787741713,"headline":"1 Surging Stock for Long-Term Investors and 2 That Underwhelm"}, {"id":141351198,"url":"https://finnhub.io/api/news?id=2adf4bf7dafa87a5d2a094ed6a61a6bf2425c55fc959d4ac16ad5c7df45ef494","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.","category":"company","datetime":1787567376,"headline":"1 Profitable Stock to Own for Decades and 2 We Turn Down"}, {"id":141279422,"url":"https://finnhub.io/api/news?id=6923c1cc8f112e10dd5ad9d09823f56d409c83dd9e29bc30f7d851606e748f6b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"BIO's digital PCR gains and recurring diagnostics base support growth, but a 40.2X forward P/E and muted 2026 outlook keep valuation risk in focus.","category":"company","datetime":1787326260,"headline":"Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?"}, {"id":141285994,"url":"https://finnhub.io/api/news?id=daf4a629089d8f9e095f46c70670711c9ee0c32ab5dca24482a04c58e554bb62","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Bio-Techne has outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.","category":"company","datetime":1787050238,"headline":"Is Wall Street Bullish or Bearish on Bio-Techne Stock?"}, {"id":141285995,"url":"https://finnhub.io/api/news?id=9d830f74e586b86a2df937c7d17ccf401031341507955ec275356e50261935d3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.","category":"company","datetime":1787007020,"headline":"3 High-Flying Stocks We Approach with Caution"}, {"id":141219177,"url":"https://finnhub.io/api/news?id=9dc21aea1bd671a42c17cf25683ce0b07533c7514480b856f307022b024fa85f","image":"","source":"Benzinga","related":"TECH","summary":"Wells Fargo analyst Brandon Couillard downgrades Bio-Techne (NASDAQ:TECH) from Overweight to Equal-Weight and raises the price target from $62 to $73.","category":"company","datetime":1786642576,"headline":"Wells Fargo Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73"}, {"id":141206752,"url":"https://finnhub.io/api/news?id=659ee02b225f8ed4a921b6c898a8d79914a526a79eab67069f99e681ffb2582e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.","category":"company","datetime":1786626060,"headline":"TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises"}, {"id":141204890,"url":"https://finnhub.io/api/news?id=9406225dd488595e8f2ad879c7709d8811f292e4cdbc3e751afe48f8f25b325b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Bio-Techne Corporation (NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version incorrectly stated the shareholder of record date as August 17, 2026. The correct shareholder of record date is August 24, 2026. All other information contained in the dividend announcement remains unchanged.","category":"company","datetime":1786617000,"headline":"Bio-Techne Corrects Dividend Announcement"}, {"id":141204891,"url":"https://finnhub.io/api/news?id=145fc12944ce1e55b01af88717d7fcd693646a77f5e8c53179970f0cfe5a49d6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Techne (TECH) delivered earnings and revenue surprises of 0.00% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1786535402,"headline":"Techne (TECH) Q4 Earnings Meet Estimates"}, {"id":141202745,"url":"https://finnhub.io/api/news?id=ede2069c356f711c5c50a96d08642cfb212030b7caf9c085e6134f46c062f61d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Life sciences company Bio-Techne (NASDAQ:TECH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.3% year on year to $321.2 million. Its non-GAAP profit of $0.52 per share was in line with analysts’ consensus estimates.","category":"company","datetime":1786534647,"headline":"Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales"}, {"id":141202747,"url":"https://finnhub.io/api/news?id=a7e01a424982cbf1b9eefe452d652dad9b4a7c63f36785bac63834e8044fbfcd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026. The quarterly dividend will be payable August 28, 2026, to all common shareholders of record on August 17, 2026. Future cash dividends will be considered by the Board of Directors on a quarterly basis.","category":"company","datetime":1786530600,"headline":"Bio-Techne Declares Dividend"}, {"id":141202746,"url":"https://finnhub.io/api/news?id=c0f2ff78f72475d1797326fe1bba1f4f571bb5e8d8efbe477118d9131dfd087d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"TECH","summary":"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2026.","category":"company","datetime":1786530600,"headline":"Bio-Techne Releases Fourth Quarter Fiscal 2026 Results"}, {"id":141197930,"url":"https://finnhub.io/api/news?id=bc376ed2ba05725913becda94402bfb8027c2f2b313a98323c8553dc2a67c224","image":"","source":"Benzinga","related":"TECH","summary":"Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. This is a 1.89 percent decrease over earnings of $0.53 per share from the same period last year. The","category":"company","datetime":1786516866,"headline":"Bio-Techne Q4 Adj. EPS $0.52, Inline, Sales $321.191M Beat $314.679M Estimate"}
data_source finnhub_news_keyword_model
article_count 4
negative_hits 0
positive_hits 1
recomputed_at_score true
sentiment_score_raw 0.6
source_article_count 18
discarded_article_count 14
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 2.5 5/110 50% 2.5
資金流 5.2 20/110 26% 5.2
市場環境 12.2 15/110 81.33% 12.2
催化劑 2 20/110 10% 2
風險管理 7.8 10/110 78% 7.8
技術信號 21.1 30/110 70.33% 21.1
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 1/50
ret_5d 0
max_score 50
max_total 50
raw_total 1
vcp_bonus 0
vol_ratio 0.8543
ret_points 0
vol_points 0
range_ratio 0.7906
volat_points 0
day_range_pct 0.0024
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 0.2401
turnoverUsdM 148.9143
liquidityPoints 0.4
volatilityPoints 1.2
rrPoints 1.8

stopLevels

symbol US.TECH
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 71.9628

strength_details

ma_score 2
atr_score 2.5
rsi_score 2
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 5
stop_loss_percent 0.5
take_profit_price 75.9255
target_multiplier 1.9
technical_strength 1.75
take_profit_percent 5
positionPoints 1.6
stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.6667
stopLossPercent 3
diversificationPoints 2

Calculation audit log

基本面分析總分: 2.5/5分
資金流分析總分: 5.2/20分
市場環境分析總分: 12.2/15分
催化劑分析: 2/20分
風險管理總分: 7.8/10分
技術信號分析總分: 21.1/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 71.43
atr
atr 0.1736
rule ATR / current price; lower volatility scores higher
score 8
atr_pct 0.24
cci
rule Cursor_18.24 CCI bands
level 平衡
score 6
value 17.13
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.1483
kdj
d 47.5
j 50.85
k 48.62
rule Cursor_18.24 K/D cross
score 4
signal 金叉
mfi
rule Cursor_18.24 MFI bands
level 超賣或超買風險
score 2
value 37.05
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 2
trend 資金流出
value 67935713
recentSlope -338128.7
previousSlope -5680
rsi
value 53.06
sar
rule Cursor_18.24 Parabolic SAR
score 6
trend 下降
value 72.5003
position SAR接近價
distancePct 0.26
previousTrend 下降
ma50
value 71.8724
macd
macd 0.4102
trend 中性偏多
signal 0.5722
histogram -0.162
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 2
value 72.3311
position <VWAP
consecutiveAbove 0
volume
rule Cursor_18.24 volume ratio
level 無力
ratio 0.88
score 4
avgVolume 2346639
currentVolume 2059387
derived
ma20 72.327
ma50 71.8724
prevClose 72.43
avgVolume10 1981709
avgVolume20 2346639
changePercent -0.17
avgVolumeForScore 2346639
ma_cross
ma20 72.327
ma50 71.8724
rule Cursor_18.24 MA20/MA50 cross
cross 接近
score 6
prevMa20 72.3175
prevMa50 71.8462
spreadPct 0.63
isVolumeBreakout false
bollinger
lower 72.133
upper 72.521
position 中間
rsi_short
value 46.55
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.88

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 0.24007744433688286,
        "turnoverUsdM": 148.91427397,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1.2
      }
    },
    "rrPoints": 1.8,
    "stopLevels": {
      "symbol": "US.TECH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 71.9628,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2.5,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 5,
      "stop_loss_percent": 0.5,
      "take_profit_price": 75.9255,
      "target_multiplier": 1.9,
      "technical_strength": 1.75,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.6666666666666667,
    "stopLossPercent": 3,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 55.8,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 54.8,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 1
  },
  "market": {
    "ma20": 72.327,
    "ma50": 71.8724,
    "close": 72.31,
    "prevClose": 72.43,
    "avgVolume20": 2346639,
    "volumeRatio": 0.88,
    "changePercent": -0.17
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 1,
    "details": {
      "ret_5d": 0,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 1,
      "vcp_bonus": 0,
      "vol_ratio": 0.8543242295829366,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.7905627396957391,
      "volat_points": 0,
      "day_range_pct": 0.0023509887982296708,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 55.8,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.5,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 50,
        "contribution": 2.5
      },
      {
        "raw": 5.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 26,
        "contribution": 5.2
      },
      {
        "raw": 12.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 81.33,
        "contribution": 12.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 78,
        "contribution": 7.8
      },
      {
        "raw": 21.1,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 70.33,
        "contribution": 21.1
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 54.8,
    "details": [
      "基本面分析總分: 2.5/5分",
      "資金流分析總分: 5.2/20分",
      "市場環境分析總分: 12.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.8/10分",
      "技術信號分析總分: 21.1/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.5,
      "資金流": 5.2,
      "市場環境": 12.2,
      "情緒分析": 4,
      "技術信號": 21.1,
      "風險管理": 7.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 4,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 148.91427397,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.TECH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "優秀",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.3
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 717.3850005500001,
                "ma50": 711.3217994399997,
                "name": "QQQ",
                "close": 718.35999,
                "points": 2
              },
              "spy": {
                "ma20": 768.6994929500001,
                "ma50": 757.5966012200001,
                "name": "SPY",
                "close": 765.96002,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 0.24007744433688286,
          "atrPoints": 4,
          "cciPoints": 2.4,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 4,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141365716,
                "url": "https://finnhub.io/api/news?id=a5ef3603445d8aa9a0dd109ccf0a962292f51f02adabd49ffa75d0ac6f6393df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bio-Techne (NASDAQ:TECH) and its peers.",
                "category": "company",
                "datetime": 1788214120,
                "headline": "Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks"
              },
              {
                "id": 141206752,
                "url": "https://finnhub.io/api/news?id=659ee02b225f8ed4a921b6c898a8d79914a526a79eab67069f99e681ffb2582e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.",
                "category": "company",
                "datetime": 1786626060,
                "headline": "TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises"
              },
              {
                "id": 141204891,
                "url": "https://finnhub.io/api/news?id=145fc12944ce1e55b01af88717d7fcd693646a77f5e8c53179970f0cfe5a49d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Techne (TECH) delivered earnings and revenue surprises of 0.00% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1786535402,
                "headline": "Techne (TECH) Q4 Earnings Meet Estimates"
              },
              {
                "id": 141202745,
                "url": "https://finnhub.io/api/news?id=ede2069c356f711c5c50a96d08642cfb212030b7caf9c085e6134f46c062f61d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.3% year on year to $321.2 million. Its non-GAAP profit of $0.52 per share was in line with analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786534647,
                "headline": "Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales"
              }
            ],
            "raw_source": [
              {
                "id": 141949006,
                "url": "https://finnhub.io/api/news?id=00df6df6df67101935570b3d09b4f6fb117c7f4bf5fcbd493dfc9d008f76108f",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "TECH",
                "summary": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session.",
                "category": "company",
                "datetime": 1788870900,
                "headline": "These S&P500 stocks are moving in today's pre-market session"
              },
              {
                "id": 141365715,
                "url": "https://finnhub.io/api/news?id=ee3edec51f2a0769452f44c0254fa97b00f03c804dffd9bcb7fd5748b9ec87a4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced significant progress toward its climate and sustainability objectives, including validation of its greenhouse gas reduction targets by the Science Based Targets initiative (SBTi) and substantial reductions in operational emissions during fiscal year 2026.",
                "category": "company",
                "datetime": 1788262200,
                "headline": "Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals"
              },
              {
                "id": 141371333,
                "url": "https://finnhub.io/api/news?id=530e9947363819acf6e2f8d541c54ea3bd19cbcc5e4b1a633a9b1554f43e1d1f",
                "image": "",
                "source": "Benzinga",
                "related": "TECH",
                "summary": "Fiscal 2026 highlights:Science Based Targets initiative validates Bio-Techne&#39;s Scope 1, 2 and 3 greenhouse gas reduction targetsMarket-based Scope 1 and 2 emissions reduced 49% year-over-yearMore than half of the",
                "category": "company",
                "datetime": 1788244574,
                "headline": "Bio-Techne Announces SBTi Validation Of 70% Scope 1 & 2 Emissions Reduction Target By FY2031 And Supplier Engagement Commitment, Reporting Significant Operational Emissions Cuts In FY2026"
              },
              {
                "id": 141365716,
                "url": "https://finnhub.io/api/news?id=a5ef3603445d8aa9a0dd109ccf0a962292f51f02adabd49ffa75d0ac6f6393df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bio-Techne (NASDAQ:TECH) and its peers.",
                "category": "company",
                "datetime": 1788214120,
                "headline": "Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks"
              },
              {
                "id": 141326656,
                "url": "https://finnhub.io/api/news?id=f0ee289a15577c07a4f88b461b3b9df0cab874642345723232053d6898832f08",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972341389/image_1972341389.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TECH",
                "summary": "Ruane, Cunniff & Goldfarb Q2 2026 13F: key holdings, new buys & trims, and Sequoia Fund vs S&P 500. Read here for a detailed investment analysis.",
                "category": "company",
                "datetime": 1787781184,
                "headline": "Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2026 Update"
              },
              {
                "id": 141365510,
                "url": "https://finnhub.io/api/news?id=db75d1ced2a8c3d0024bd9d7d5a4f5c9b286c68130e8836fd45d69e34e43e3f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.",
                "category": "company",
                "datetime": 1787741713,
                "headline": "1 Surging  Stock for Long-Term Investors and 2 That Underwhelm"
              },
              {
                "id": 141351198,
                "url": "https://finnhub.io/api/news?id=2adf4bf7dafa87a5d2a094ed6a61a6bf2425c55fc959d4ac16ad5c7df45ef494",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
                "category": "company",
                "datetime": 1787567376,
                "headline": "1 Profitable Stock to Own for Decades and 2 We Turn Down"
              },
              {
                "id": 141279422,
                "url": "https://finnhub.io/api/news?id=6923c1cc8f112e10dd5ad9d09823f56d409c83dd9e29bc30f7d851606e748f6b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "BIO's digital PCR gains and recurring diagnostics base support growth, but a 40.2X forward P/E and muted 2026 outlook keep valuation risk in focus.",
                "category": "company",
                "datetime": 1787326260,
                "headline": "Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?"
              },
              {
                "id": 141285994,
                "url": "https://finnhub.io/api/news?id=daf4a629089d8f9e095f46c70670711c9ee0c32ab5dca24482a04c58e554bb62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne has outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.",
                "category": "company",
                "datetime": 1787050238,
                "headline": "Is Wall Street Bullish or Bearish on Bio-Techne Stock?"
              },
              {
                "id": 141285995,
                "url": "https://finnhub.io/api/news?id=9d830f74e586b86a2df937c7d17ccf401031341507955ec275356e50261935d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.",
                "category": "company",
                "datetime": 1787007020,
                "headline": "3 High-Flying Stocks We Approach with Caution"
              },
              {
                "id": 141219177,
                "url": "https://finnhub.io/api/news?id=9dc21aea1bd671a42c17cf25683ce0b07533c7514480b856f307022b024fa85f",
                "image": "",
                "source": "Benzinga",
                "related": "TECH",
                "summary": "Wells Fargo  analyst Brandon Couillard   downgrades Bio-Techne (NASDAQ:TECH) from Overweight to Equal-Weight and raises the price target from $62 to $73.",
                "category": "company",
                "datetime": 1786642576,
                "headline": "Wells Fargo Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73"
              },
              {
                "id": 141206752,
                "url": "https://finnhub.io/api/news?id=659ee02b225f8ed4a921b6c898a8d79914a526a79eab67069f99e681ffb2582e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.",
                "category": "company",
                "datetime": 1786626060,
                "headline": "TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises"
              },
              {
                "id": 141204890,
                "url": "https://finnhub.io/api/news?id=9406225dd488595e8f2ad879c7709d8811f292e4cdbc3e751afe48f8f25b325b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne Corporation (NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version incorrectly stated the shareholder of record date as August 17, 2026. The correct shareholder of record date is August 24, 2026. All other information contained in the dividend announcement remains unchanged.",
                "category": "company",
                "datetime": 1786617000,
                "headline": "Bio-Techne Corrects Dividend Announcement"
              },
              {
                "id": 141204891,
                "url": "https://finnhub.io/api/news?id=145fc12944ce1e55b01af88717d7fcd693646a77f5e8c53179970f0cfe5a49d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Techne (TECH) delivered earnings and revenue surprises of 0.00% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1786535402,
                "headline": "Techne (TECH) Q4 Earnings Meet Estimates"
              },
              {
                "id": 141202745,
                "url": "https://finnhub.io/api/news?id=ede2069c356f711c5c50a96d08642cfb212030b7caf9c085e6134f46c062f61d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.3% year on year to $321.2 million. Its non-GAAP profit of $0.52 per share was in line with analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786534647,
                "headline": "Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales"
              },
              {
                "id": 141202747,
                "url": "https://finnhub.io/api/news?id=a7e01a424982cbf1b9eefe452d652dad9b4a7c63f36785bac63834e8044fbfcd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026. The quarterly dividend will be payable August 28, 2026, to all common shareholders of record on August 17, 2026. Future cash dividends will be considered by the Board of Directors on a quarterly basis.",
                "category": "company",
                "datetime": 1786530600,
                "headline": "Bio-Techne Declares Dividend"
              },
              {
                "id": 141202746,
                "url": "https://finnhub.io/api/news?id=c0f2ff78f72475d1797326fe1bba1f4f571bb5e8d8efbe477118d9131dfd087d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2026.",
                "category": "company",
                "datetime": 1786530600,
                "headline": "Bio-Techne Releases Fourth Quarter Fiscal 2026 Results"
              },
              {
                "id": 141197930,
                "url": "https://finnhub.io/api/news?id=bc376ed2ba05725913becda94402bfb8027c2f2b313a98323c8553dc2a67c224",
                "image": "",
                "source": "Benzinga",
                "related": "TECH",
                "summary": "Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. This is a 1.89 percent decrease over earnings of $0.53 per share from the same period last year.  The",
                "category": "company",
                "datetime": 1786516866,
                "headline": "Bio-Techne Q4 Adj. EPS $0.52, Inline, Sales $321.191M Beat $314.679M Estimate"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 4,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 18,
            "discarded_article_count": 14
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 21.1,
        "grade": "良好",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.7999999999999998,
          "vcpPoints": 3,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 3,
            "vcp_reason": "波幅收縮(1.4%→0.6%);量縮(v10/v30=0.64);跌縮量(近10日5日);站上MA50;Ready=Y;Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 3071610,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 1975930,
              "avg_vol_20": 2410545,
              "avg_vol_30": 3071610,
              "range_pct_10": 0.006084912183653681,
              "range_pct_20": 0.008574194440603021,
              "range_pct_30": 0.014382519706817953,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.6432880476362559,
              "dist_to_20d_high": 0.004268796474800361,
              "down_shrink_days": 5,
              "breakout_level_20d": 72.62,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.42307692307691835
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 3.2,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 0.24007744433688286,
              "turnoverUsdM": 148.91427397,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1.2
            }
          },
          "rrPoints": 1.8,
          "stopLevels": {
            "symbol": "US.TECH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 71.9628,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2.5,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 5,
            "stop_loss_percent": 0.5,
            "take_profit_price": 75.9255,
            "target_multiplier": 1.9,
            "technical_strength": 1.75,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.6666666666666667,
          "stopLossPercent": 3,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 71.43,
    "atr": {
      "atr": 0.1736,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 8,
      "atr_pct": 0.24
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "平衡",
      "score": 6,
      "value": 17.13
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1483
    },
    "kdj": {
      "d": 47.5,
      "j": 50.85,
      "k": 48.62,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 37.05
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": 67935713,
      "recentSlope": -338128.7,
      "previousSlope": -5680
    },
    "rsi": 53.06,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 6,
      "trend": "下降",
      "value": 72.5003,
      "position": "SAR接近價",
      "distancePct": 0.26,
      "previousTrend": "下降"
    },
    "ma50": 71.8724,
    "macd": {
      "macd": 0.41023369370164176,
      "trend": "中性偏多",
      "signal": 0.572200037810684,
      "histogram": -0.1619663441090422
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 72.3311,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.88,
      "score": 4,
      "avgVolume": 2346639,
      "currentVolume": 2059387
    },
    "derived": {
      "ma20": 72.327,
      "ma50": 71.8724,
      "prevClose": 72.43,
      "avgVolume10": 1981709,
      "avgVolume20": 2346639,
      "changePercent": -0.17,
      "avgVolumeForScore": 2346639
    },
    "ma_cross": {
      "ma20": 72.327,
      "ma50": 71.8724,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 72.3175,
      "prevMa50": 71.8462,
      "spreadPct": 0.63,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 72.133,
      "upper": 72.521,
      "position": "中間"
    },
    "rsi_short": 46.55,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.88
    }
  }
}

Raw metrics JSON

{
  "close": 72.31,
  "volume": 2059387,
  "changePercent": -0.17
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.